|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
2008-10-8
|
|
pubmed:abstractText |
Although the phosphatidylinositide 3-kinase (PI3K)/Akt pathway has been reported to contribute to the malignant growth of multiple myeloma (MM), the true relevance of Akt kinases for this disease is still unclear. In particular, functional analyses in primary tumor cells and genetic target validation experiments are missing. Here, we used combined functional and molecular analyses to determine the importance of Akt activity in a large panel of primary MM samples and in MM cell lines. Akt down-regulation with isoform-specific siRNA constructs or with an Akt1/2-specific pharmacologic inhibitor strongly induced apoptosis in approximately half of the primary MM samples analyzed. Sensitivity to Akt inhibition strongly correlated with the activation status of Akt as determined by immunohistochemistry, phospho-Akt-specific flow cytometry, and Western analysis. Additional blockade of the MAPK and the IL-6R/STAT3 pathways was often not sufficient to decrease the viability of MM cells resilient to Akt inhibition. Taken together, these experiments led to the identification of 2 myeloma subgroups: Akt-dependent and Akt-independent MM.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1528-0020
|
|
pubmed:author |
pubmed-author:AndrulisMindaugasM,
pubmed-author:BargouRalf CRC,
pubmed-author:ChatterjeeManikM,
pubmed-author:EinseleHermannH,
pubmed-author:GattenlöhnerStefanS,
pubmed-author:GreinerAxelA,
pubmed-author:HaralambievaEugeniaE,
pubmed-author:Müller-HermelinkHans-KonradHK,
pubmed-author:RathJörg CJC,
pubmed-author:StühmerThorstenT,
pubmed-author:WesemeierCarmenC,
pubmed-author:ZöllingerAngelaA
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
112
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3403-11
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:18635812-Apoptosis,
pubmed-meshheading:18635812-Bone Marrow Cells,
pubmed-meshheading:18635812-Cell Line, Tumor,
pubmed-meshheading:18635812-Flow Cytometry,
pubmed-meshheading:18635812-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:18635812-Humans,
pubmed-meshheading:18635812-Models, Biological,
pubmed-meshheading:18635812-Multiple Myeloma,
pubmed-meshheading:18635812-Phosphatidylinositol 3-Kinases,
pubmed-meshheading:18635812-Proto-Oncogene Proteins c-akt,
pubmed-meshheading:18635812-Receptors, Interleukin-6,
pubmed-meshheading:18635812-STAT3 Transcription Factor,
pubmed-meshheading:18635812-Signal Transduction,
pubmed-meshheading:18635812-Stem Cells
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
Combined functional and molecular analysis of tumor cell signaling defines 2 distinct myeloma subgroups: Akt-dependent and Akt-independent multiple myeloma.
|
|
pubmed:affiliation |
Department of Internal Medicine II, Division of Hematology, University Hospital of Würzburg, Würzburg, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
